Altogether, these data highlight the clinical relevance of CXCR6+ CD127− Tr1 cells as a functionally suppressive cell subset that likely aids in the acquisition of clinical immunity to malaria but may facilitate parasite persistence. Here, CXCR6 is linked to malaria.